Michele A Gadd Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

1/2022	Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions.
1/2020	Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or Biopsies.
11/2019	Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
10/2016	Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
1/2014	Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
12/2012	The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.
1/2008	Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michele A Gadd Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 05/2021 - 01/2003
19	Neoplasms (Cancer) 05/2021 - 01/2003
7	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 01/2008
5	Residual Neoplasm 05/2021 - 10/2016
3	Margins of Excision 06/2020 - 07/2003
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2022
2	Hyperplasia 09/2017 - 12/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	COVID-19 10/2020
1	Breast Carcinoma In Situ 12/2012
1	Neoplasm Micrometastasis 01/2008
1	Neoplasm Metastasis (Metastasis) 04/2004
1	Melanoma (Melanoma, Malignant) 04/2004
1	Hematoma 07/2003
1	Abscess 07/2003
1	Hemorrhage 07/2003

Drug/Important Bio-Agent (IBA)

3	Peptide Hydrolases (Proteases)FDA Link 05/2021 - 06/2020
3	Estrogen ReceptorsIBA 10/2020 - 05/2010
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2020
1	CathepsinsIBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Tamoxifen FDA LinkGeneric 01/2014
1	Phenobarbital (Luminal)FDA Link 05/2010
1	Biological ProductsIBA 05/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2003
1	AnthracyclinesIBA 01/2003
1	human ERBB2 proteinIBA 01/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2003
1	Trastuzumab (Herceptin)FDA Link 01/2003

Therapy/Procedure

13	Segmental Mastectomy (Lumpectomy) 01/2022 - 09/2008
8	Mastectomy (Mammectomy) 01/2020 - 01/2008
5	Therapeutics 10/2020 - 01/2003
3	Radiotherapy 01/2021 - 07/2003
3	Chemoprevention 09/2017 - 12/2012
3	Lymph Node Excision (Lymph Node Dissection) 01/2008 - 04/2004
2	Neoadjuvant Therapy 11/2020 - 10/2005
2	Prophylactic Mastectomy 11/2019 - 07/2014
2	Brachytherapy 07/2012 - 07/2003
2	Drug Therapy (Chemotherapy) 10/2005 - 01/2003
1	Radio Frequency Identification Device 11/2020
1	Operative Surgical Procedures 10/2020
1	Mammaplasty (Breast Reconstruction) 10/2019
1	Catheters 07/2003